Novartis AG - Cash Flows Other Operating

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Cash-Flows-Other-Operating" stands at 2.04 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

Novartis AG's third quarter result of 0.266 Billion USD for the item "Cash Flows Other Operating" represents a decrease of -47.53 percent compared to it's second quarter result.

Also, Novartis AG's third quarter result of 0.266 Billion USD for the item "Cash Flows Other Operating" represents an increase of 33.00 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Novartis AG's third quarter result of 2.04 Billion USD for the item "Cash Flows Other Operating" represents an increase of 3.35 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.02 Billion United States Dollars compared to the value the year prior.
The 1 year change is 3.02 Billion United States Dollars.
The 3 year change is 0.25 Billion United States Dollars.
The 5 year change is 0.059 Billion United States Dollars.
The 10 year change is 3.04 Billion United States Dollars.

The Serie's long term average value is 0.372 Billion United States Dollars. It's latest available value, on 09/30/2025, is 1.66 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 09/30/2017, to it's latest available value, on 09/30/2025, is +3.62 Billion.
The Serie's change in United States Dollars from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -0.142 Billion.